Assess the Efficacy and Safety of INCB054707 in Participants

With Hidradenitis Suppurativa

ID# NCT04476043

 

Recruitment Status: Recruiting

Estimated Study Completion Date: July 28, 2022

HS Connect listed this: September 2020

 

Sponsor: Incyte Corporation

Information provided by (Responsible Party): Incyte Corporation

 

Brief Summary:

 

To evaluate the efficacy and safety of INCB054707 in participants with hidradenitis suppurativa over a 16-week placebo-controlled treatment period followed by a 36 -week open-label extension period.

 

Please link for complete trial details:

https://clinicaltrials.gov/ct2/show/NCT04476043

 

Location: Multiple US locations. Please see link provided above for all location details and to confirm your location is recruiting.

 

Contact Information: 

 

Contact: Incyte Corporation Call Center (US) Phone: 1.855.463.3463 Email:

 

Contact: Incyte Corporation Call Center (ex-US) Phone: +800 00027423 Email: